Drug Discovery & Development
News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.
DNAnexus, Panomics Partner to Offer Multiomics Data Analysis Platform for Biopharma Researchers
The collaborators hope their integrated product will boost transcriptomics and proteomics data analysis workflows for biomarker discovery and drug repurposing.
The startup is mining the microbiome for genes encoding proteins with drug-like activities relevant to treat oncology, immunology, and metabolic disorders.
The company suggested that its shift toward early-stage work reflects growing confidence in its platform among its pharma customers.
23andMe to Lay Off 40 Percent of Workforce, End Therapeutics Program as Q2 Revenues Dip 12 Percent
Declining PGS kit sales and telehealth orders drove falling consumer services revenues as the company announced a massive restructuring to reduce costs.
Aignostics Raises $34M in Series B Round
The company develops AI technologies to analyze a range of pathology data derived from tissue samples for biopharma clients.